Skip to main content
Back to Deerfield

Deerfield's Genetics Portfolio

Browse 9 Genetics companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Genetics Companies
9
Total Funding in Genetics
$737.6M

Genetics Portfolio Companies (9)

Export
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsProduct Research

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Lake Forest, United States
March 2022
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BioinformaticsBiotechnologyGenetics

Actio Biosciences is a research center that develops drugs for rare diseases.

San Diego, United States
June 2025
$66.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Cambridge, United States
January 2024
$100.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

London, United Kingdom
December 2025
$26.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsMedical

Ascend helps make and sell gene therapy treatments. We know a lot about how to create and share these special medicines.

Alachua, United States
November 2024
$130.6M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth Care

Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.

Champaign, United States
December 2020
$25.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth Care

Concert Genetics provides physicians with the information they need to find the right test for their patients.

Franklin, United States
January 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio